首页> 外文OA文献 >PD14-11 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ) IN A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)

【2h】

PD14-11 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ) IN A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)

机译：PD14-11与前瞻性观察研究（Capristaana）在Cabazitaxel（CBZ）治疗的转移阉割抗阉割前列腺癌（MCRPC）患者中有关的寿命寿命（HRQ1）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Angelika Pichler; Gisoo Barnes; Jana Katolicka; Hana Korunkova; Antoaneta Tomova; Marwan Ghosn; Fadi El Karak; Irina Koroleva; Joseph Makdessi; Ayse Ozatilgan; Simon Hitier; Joan Carles;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel ( CAPRISTANA CAPRISTANA ) [J] . Carles Joan, Pichler Angelika, Korunkova Hana, BJU international . 2019,第3期

机译：在先前用多西紫杉醇（Capristana Capristana）治疗的转移阉割抗阉割前列腺癌患者中的观察到.Cabazitaxel
2. Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone [J] . Fred Saad, Eric Winquist, Stacey Hubay, Canadian Urological Association Journal . 2016,第3a4期

机译：卡巴他赛在加拿大转移性去势抵抗性前列腺癌患者中的疗效，生活质量和安全性
3. Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) (NCT01254279) [J] . Bahl Amit, Masson Susan, Malik Zafar, BJU international . 2015,第6期

机译：英国抢先治疗计划（EAP）中使用卡巴他赛治疗的转移性去势抵抗性前列腺癌患者的最终生活质量和安全性数据（NCT01254279）
4. Significance of the −2propsa index and the prostate health index in patients with prostate cancer: A literature review and data of the Russian prospective study [C] . K. B. Kolontarev, D. Yu. Pushkar, A. V. Govorov, Proceedings of the 2017 International Conference "Quality Management, Transport and Information Security, Information Technologies" . 2017

机译：−2propsa指数和前列腺健康指数在前列腺癌患者中的意义：一项俄罗斯前瞻性研究的文献综述和数据
5. A prospective study examining the relationship between health-related quality of life and survival in pediatric cancer patients. [D] . Stender, Jennifer Ryan. 2003

机译：一项前瞻性研究，探讨了小儿癌症患者健康相关的生活质量与生存之间的关系。
6. An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer [O] . A. Thiery-Vuillemin, K. Fizazi, O. Sartor, 2021

机译：在患有转移阉割抵抗前列腺癌患者中评估CABAZITAXEL的III阶段PROVESICA和Firstana研究中的健康相关生活质量分析
7. An observational, multicentre study of cabazitaxel in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (CAPRISTANA) [O] . Joan Carles, Angelika Pichler, Hana Korunkova, 2018

机译：在先前用多紫杉醇（Capristana）治疗的转移阉割抗阉割前列腺癌患者的患者的观察到。

PD14-11 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) TREATED WITH CABAZITAXEL (CBZ) IN A PROSPECTIVE OBSERVATIONAL STUDY (CAPRISTANA)

著录项

引文网络

相似文献

相关主题

期刊订阅